Plain-English translation of NCT06255535 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called repetitive transcranial magnetic stimulation (rTMS), which uses magnetic pulses to stimulate specific areas of the brain. The trial focuses on people ages 6–30 with autism spectrum disorder who also have an intellectual disability. Researchers believe that stimulating a region of the brain involved in decision-making and self-control might help improve autism-related symptoms and behaviors.
Currently, there are very few effective treatments for older teens and adults with low-functioning autism, even though they often need a lot of support in their daily lives. Early research suggests that this type of brain stimulation has helped people with other psychiatric and neurological conditions, so researchers want to see if it could help people with autism too.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to receive either active brain stimulation or a placebo (sham) treatment that feels similar but does not stimulate the brain. The treatment lasts 12 weeks, with sessions five days a week—three short stimulation sessions per day with 30-minute breaks between them. You will have brain imaging scans before treatment starts and will be evaluated again after the 12 weeks to see if symptoms have improved.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
China